Medical Research News

RSS

New $1.7 million project to identify potential COVID-19 treatments

CSIRO, Australia's national science agency, will spearhead a $1.7 million project to identify new treatments for COVID-19, including 'long-COVID'.

2 Jul 2021

Curtin researchers awarded almost $500,000 funding to help improve care for TBI patients

Curtin University researchers have been awarded almost $500,000 in Federal Government funding to help improve care for people with traumatic brain injury (TBI), including those in rural, remote and Aboriginal communities.

2 Jul 2021

Research highlights long-lasting effects of childhood reading problems on cognitive skills

Reading difficulties in childhood are linked to poorer cognitive skills in older age and a greater likelihood of registering scores indicative of dementia risk, suggests research published online in the Journal of Epidemiology & Community Health.

2 Jul 2021

High omega 3 diet associated with reduction of headaches

Eating a diet rich in omega 3 (n-3) fatty acids reduces the frequency of headaches compared with a diet with normal intake of omega 3 and omega 6 (n-6) fatty acids, finds a study published by The BMJ today.

2 Jul 2021

Tell-tale signs of high stroke risk may appear a decade in advance

The tell-tale signs of a person’s susceptibility to a stroke may appear up to 10 years before the event, suggests research published online in the Journal of Neurology Neurosurgery & Psychiatry.

2 Jul 2021

Stool transplant may be worth exploring as treatment option for COVID-19

It might be worth exploring stool transplant to treat COVID-19 infection, suggest doctors in a letter published online in the journal Gut, after they used the procedure in two patients to prevent the recurrence of another bacterial infection.

2 Jul 2021

Flinders University sleep experts test new mattress sensor

Flinders University sleep experts are becoming embedded in a new trial to help people with their individual sleep disorders - via tests on a new mattress sensor.

2 Jul 2021

Replication of SARS-CoV-2 in nasal ciliated cells could provide a new vaccination target

Researchers have found that nasal ciliated cells are targeted at the onset of COVID-19 infection, which may help to establish nasal mucosal immunity.

2 Jul 2021

New PET imaging method tracks immunotherapeutic efficacy in mouse models

Several cancer tumors grow through immunosuppression; that is, they manipulate biological systems in their microenvironments and signal to a specific set of immune cells--those that clear out aberrant cells--to stop acting. It is no wonder that immunotherapy designed to re-establish anti-tumor immunity is rapidly becoming the treatment of choice for these cancers.

2 Jul 2021

Extreme longevity likely to rise slowly by the end of the 21st century

The number of people who live past the age of 100 has been on the rise for decades, up to nearly half a million people worldwide.

2 Jul 2021

Researchers seek to quantify immunogenicity of COVID vaccines in immunocompromised patients

Evidence continues to mount that vaccination against COVID-19, most notably the Pfizer and Moderna vaccines, produces robust, durable protection in the vast majority of recipients.

2 Jul 2021

Immunity to SARS-CoV-2 could last longer than originally believed

One year after infection by SARS-CoV-2, most people maintain anti-Spike antibodies regardless of the severity of their symptoms, according to a study with healthcare workers co-led by the Barcelona Institute for Global Health (ISGlobal), the Catalan Health Institute (ICS) and the Jordi Gol Institute (IDIAP JG), with the collaboration of the Daniel Bravo Andreu Private Foundation.

2 Jul 2021

Study evaluates the difference in weight loss caused by two antidiabetic medications

Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.

2 Jul 2021

Research associates prior encounter with seasonal coronavirus to milder COVID-19 symptoms

A study by Stanford University School of Medicine investigators hints that people with COVID-19 may experience milder symptoms if certain cells of their immune systems "remember" previous encounters with seasonal coronaviruses -- the ones that cause about a quarter of the common colds kids get.

2 Jul 2021

Is there a link between circadian rhythms and COVID-19 severity?

This study showed that the time of day of SARS-CoV-2 infection could impact the severity of the viral infection and the host immune response.

1 Jul 2021

Engineered T cells prevent translational shutdown in SARS-CoV-2 infected cells

In a paper recently uploaded to the preprint server bioRxiv* by Schamel et al. (June 25th, 2021) engineered T cells against SARS-CoV-2 are tested against a range of cells in vitro, finding that the treatment could be used to restore cellular immune function and suppress SARS-CoV-2.

1 Jul 2021

Mutations in the spike proteins of SARS-CoV-2 select for amino acid changes, increasing protein stability

A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.

1 Jul 2021

Cryo-EM structure of neutralizing antibody 5-7 in complex with SARS CoV-2 spike

Researchers from the US recently reported the 3.7 Å resolution cryo-EM structure of an NTD-directed neutralizing antibody 5-7 that forms a complex with SARS-CoV-2 spike protein. They also presented the neutralization data against VOC and studied the recognized epitope.

1 Jul 2021

Mustard seed, wall rocket and turmeric extracts show potential against SARS-CoV-2 in vitro

Researchers in Spain have identified plant extracts that may be of interest in the search for treatments of coronavirus disease 2019 (COVID-19) and serve as a basis for future chemical, in vivo, and clinical trials.

1 Jul 2021

Grapevine leaf extract inhibits SARS-CoV-2 and HSV-1 replication in the lab

Researchers in Italy have shown that leaf extract from the common grapevine – Vitis vinifera – exhibits significant antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

1 Jul 2021

Medical Research News

New $1.7 million project to identify potential COVID-19 treatments

Curtin researchers awarded almost $500,000 funding to help improve care for TBI patients

Research highlights long-lasting effects of childhood reading problems on cognitive skills

High omega 3 diet associated with reduction of headaches

Tell-tale signs of high stroke risk may appear a decade in advance

Stool transplant may be worth exploring as treatment option for COVID-19

Flinders University sleep experts test new mattress sensor

Replication of SARS-CoV-2 in nasal ciliated cells could provide a new vaccination target

New PET imaging method tracks immunotherapeutic efficacy in mouse models

Extreme longevity likely to rise slowly by the end of the 21st century

Researchers seek to quantify immunogenicity of COVID vaccines in immunocompromised patients

Immunity to SARS-CoV-2 could last longer than originally believed

Study evaluates the difference in weight loss caused by two antidiabetic medications

Research associates prior encounter with seasonal coronavirus to milder COVID-19 symptoms

Is there a link between circadian rhythms and COVID-19 severity?

Engineered T cells prevent translational shutdown in SARS-CoV-2 infected cells

Mutations in the spike proteins of SARS-CoV-2 select for amino acid changes, increasing protein stability

Cryo-EM structure of neutralizing antibody 5-7 in complex with SARS CoV-2 spike

Mustard seed, wall rocket and turmeric extracts show potential against SARS-CoV-2 in vitro

Grapevine leaf extract inhibits SARS-CoV-2 and HSV-1 replication in the lab

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News